Abstract A 29 year old male with onset of globoid cell leukodystrophy at age 14 is described. This is the first case of enzymatically confirmed globoid cell leukodystrophy with onset of symptoms after the age of ten. This patient is unique because of the late onset and slow progression and extends the clinical spectrum of globoid cell leukodystrophy.
Case report A 29 year old male first sought medical attention at the age of 14 complaining of difficulty in walking. His birth and delivery were uncomplicated and his developmental milestones were normal. He was an average student and a good athlete who had no difficulty walking, running or playing sports. At the age of 14 he was initially noted to have a "swing" to his gait.
After clinical examination, a myelogram was performed which was reported to be normal. He was told that he had Schilder's dis- ease Electromyogram and nerve conduction studies were normal. A sural nerve biopsy, including an examination under light and electron microscopy, was normal. An MRI with T2 weighted techniques showed abnormalities in the periventricular white matter of both cerebral hemispheres (fig) . A CT scan with and without contrast was normal. Visual evoked responses revealed bilateral prolongation of the P-100 latencies. Somatosensory evoked responses showed prolonged conduction time with stimulation of the right peroneal nerve but were normal when the right median nerve was stimulated. Brainstem auditory responses were normal. Skin fibroblasts showed a beta-galactocerebrosidase activity of 0-08 nanomoles/mg hour/protein (control: 15 + 04). This test was repeated on two occasions with similar results. The father refused to be tested and his mother had died of trauma when the patient was eight years old. However, his sister's fibroblasts were tested for beta-galactocerebrosidase activity which fell in the "carrier" range. Attempts are being made to further characterise the enzyme from this patient.
Over the course of five years, his brainstem auditory responses became abnormal with prolonged latencies bilaterally. Also, the somatosensory evoked responses were slowed following stimulation of both upper and lower limbs. His cerebral MRI examinations showed slowly progressive disease bilaterally. Physical sponses were abnormal early in our patient's course and provided evidence of the extent of nervous system involvement. The somatosensory responses initially demonstrated prolonged conduction time from stimulation of the lower extremity but not from the upper extremity. This correlated with the early and more extensive involvement of the lower extremities. As the disease progressed, the evoked responses produced by stimulation of the upper extremity also became abnormal. The brainstem auditory response was initially normal but over a five year period became abnormal providing evidence of disease progression. These observations suggest that evoked responses are useful both diagnostically and in monitoring for disease progression.
Before the discovery of the enzymatic defect, two cases of presumed globoid cell leukodystrophy with onset in adulthood were diagnosed at necropsy.9"' However, pathological description is not as reliable as enzymatic confirmation." Nevertheless, globoid cell leukodystrophy should be a diagnostic consideration in selected patients, regardless of age. Our patient may represent a distinct form of globoid cell leukodystrophy separate from infantile and late infantile onset types. The clinical heterogeneity of the disease may arise from heterogeneity of the mutations causing the disease. With increased awareness of the clinical variability of this disease more patients may be recognised.
